Aresko Global Private Limited
About Aresko Global Private Limited
Data last updated:
Aresko Global Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 17 August 1992.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U70200DL1992PTC049987.
The company had an authorised share capital of ₹5.25 Cr and a paid-up capital of ₹80.04 Lakh. It was led by directors Prithipal Singh Kochhar and Rajpal Singh Kochhar.
Its last annual general meeting (AGM) was held on 06 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at 10 Jorbagh Market, New Delhi, Delhi, India – 110003.
As per the financials filed for FY 2024, the company reported a revenue of ₹18.02 Lakh. For the same year it recorded a net profit of ₹12.79 Lakh (net margin 71%) and EBITDA of ₹17.47 Lakh (EBITDA margin 97%).
Company details
CIN history
Aresko Global has one previous CIN (Corporate Identification Number): U74899DL1992PTC049987. The current CIN is U70200DL1992PTC049987, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U70200DL1992PTC049987 | Current |
| U74899DL1992PTC049987 | Previous |
Contact details
Aresko Global Private Limited's registered office is in New Delhi, Delhi.
- Registered Address10 Jorbagh Market, New Delhi, Delhi, India – 110003
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aresko Global Private Limited
FY 2024 filings availableAresko Global Private Limited reported revenue of ₹18.02 Lakh for FY 2024.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹17.47 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.79 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 97% | ||||
| Net Profit Margin | 71% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aresko Global Private Limited, buy the company report.
Board of directors of Aresko Global Private Limited
Aresko Global has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prithipal Singh Kochhar Also directs: Aresko Global LLP, I.K. Enterprises Private Limited, Suvinys Developers Private Limited and 5 more | Director | 03 Jan 2022 | 4 Years 9 Months | As last reported |
| Rajpal Singh Kochhar | Director | 03 Jan 2022 | 4 Years 9 Months | As last reported |
Peer comparison
Aresko Global Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cis Medtour Private Limited | ₹18.12 Lakh (FY 2025) | -65.0% | New Delhi, Delhi, India | |||
| Synthokind Pharmaceuticals Private Limited | ₹18.04 Lakh (FY 2025) | 0.0% | Delhi, India | |||
| Recure Healthcare Private Limited | ₹18.04 Lakh (FY 2025) | 4.0% | Rajkot, Gujarat, India | |||
| Shantilal & Co Pharma Private Limited | ₹18.04 Lakh (FY 2024) | -90.0% | Chennai, Tamil Nadu, India | |||
| Brunson Healthcare Private Limited | ₹18.02 Lakh (FY 2018) | 64.0% | Kalyan West, Maharashtra, India | |||
| Aresko Global Private Limitedthis company | ₹18.02 Lakh (FY 2024) | ₹12.79 Lakh | 71% | New Delhi, Delhi, India | ||
| Rizer Healthcare Private Limited | ₹18.01 Lakh (FY 2025) | -5.0% | Delhi, India | |||
| Aayam Pharmaceuticals Private Limited | ₹18 Lakh (FY 2025) | 6.0% | Indore, Madhya Pradesh, India | |||
| Choice Naturals Private Limited | ₹18 Lakh (FY 2019) | Mumbai, Maharashtra, India | ||||
| K.Doraiswamy Trading Co.Private Limited | ₹18 Lakh (FY 2025) | Port Blair, Andaman and Nicobar Islands, India | ||||
| Sayyam Trading Private Limited | ₹18 Lakh (FY 2025) | 35900.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Aresko Global Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aresko Global Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aresko Global Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aresko Global Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aresko Global Private Limited has 8 board changes on record since 2022: 2 appointments and 6 cessations. The latest: Inderpal Singh Kochhar ceased to be Additional Director on 30 Sep 2022.
Frequently asked questions
Aresko Global has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Aresko Global was a private limited company based in New Delhi, Delhi, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 17 August 1992 and is registered under CIN U70200DL1992PTC049987. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Aresko Global is U70200DL1992PTC049987. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aresko Global had 2 directors:
- Prithipal Singh Kochhar - Director
- Rajpal Singh Kochhar - Director
Aresko Global was incorporated on 17 August 1992. It is registered with the Registrar of Companies, Delhi.
The registered office of Aresko Global is at 10 Jorbagh Market, New Delhi, Delhi, India – 110003.
The latest financial statements of Aresko Global on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 06 September 2024. Year-wise statements from 2015 are in the company report.
Aresko Global operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
The peers of Aresko Global by revenue are Cis Medtour Private Limited, Synthokind Pharmaceuticals Private Limited, Recure Healthcare Private Limited, Shantilal & Co Pharma Private Limited, Brunson Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Inderpal Singh Kochhar ceased to be Additional Director on 30 Sep 2022. Ishpinder Kaur Kochhar ceased to be Additional Director on 30 Sep 2022. Prithipal Singh Kochhar ceased to be Additional Director on 30 Sep 2022. Aresko Global has 8 board changes on record in total.
The compliance status of Aresko Global is compliant as of 21 September 2026.